国产精品久久久久久永久牛牛,55国产福利在线视频,成人午夜精品视频在线观看

目錄產品 » 穩定細胞系 » Human Recombinant Glucagon-like Peptide 1 Receptor Stable Cell Line
CHO-K1/GLP1R/Gα15 Stable Cell Line

Figure 1. GLP-1 (7-37)-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/GLP1R/Gα15 cells. The cells were loaded with Calcium-4 prior to being stimulated with agonist GLP-1 (7-37). The intracellular calcium change was measured by FLIPRTETRA. The relative fluorescent units (RFU) were normalized and plotted against the log of the cumulative doses (5-fold dilution) of GLP-1 (7-37) (Mean ± SEM, n = 3). The EC50 of GLP-1 (7-37) on this cell was 0.14 μM.

Notes:
EC50 value is calculated with four parameter logistic equation:
Y=Bottom + (Top-Bottom)/(1+10^((LogEC50-X)*Hill Slope))
X is the logarithm of concentration. Y is the response
Y is % stimulation of RFU and starts at Bottom and goes to Top with a sigmoid shape.

CHO-K1/GLP1R/Gα15 Stable Cell Line

Figure 2. FACS analysis of cell surface expression of GLP1R on CHO-K1/GLP1R/Gα15 stable cell line. The fluorescence signal of the target protein on cell product (red) was compared to negative control (green) and detected with GLP1R Antibody (Cat. No. A01826, GenScript) followed by FITC conjugated Goat anti-Mouse IgG Antibody (H+L) (Cat. No. ab6785, Abcam).

CHO-K1/GLP1R/Gα15 Stable Cell Line

Figure 3. Dose dependent stimulation of intracellular cAMP mobilization upon treatment with calcitonin in CHO-K1/GLP1R/Gα15 cells. d2 acceptor fluorophore-labeled cAMP (Cat. No. 62AM4PEC; Revvity) and intracellular cAMP in CHO-K1/GLP1R/Gα15 cells competitively bind with Europium Cryptate-labeled anti-cAMP monoclonal antibody. The FRET signal decreases as the intracellular cAMP concentration rises and was measured by plate reader (Varioskan, Thermo Fisher). The EC50 of GLP-1 (7-37) was 1.84 nM.

CHO-K1/GLP1R/Gα15 Stable Cell Line

Recombinant CHO-K1 cells stably overexpress human glucagon-like peptide-1 receptor (GLP1R) on the surface and contain high levels of G protein Gαs to couple with the receptor in downstream signaling pathways.
M00451
詢價

聯系我們
Product Description Recombinant CHO-K1 cells stably overexpress human glucagon-like peptide-1 receptor (GLP1R) on the surface and contain high levels of G protein Gαs to couple with the receptor in downstream signaling pathways.
Culture Properties Adherent
Stability Stable through more than 16 passages with no significant changes in assay performance or expression profile.
Size Two vials of frozen cells (>1×106 per vial in 1 mL)
Storage Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received.

Culture Medium Ham’s F-12K (Kaighn’s), 10% FBS, 200 μg/ml Zeocin (Cat. No. R250-01, Life Technologies), 100 μg/ml Hygromycin B (Cat. No. 10687010, Invitrogen)
Complete Growth Medium Ham’s F-12K (Kaighn’s), 10% FBS
Freeze Medium-DATA 45% Ham’s F-12K (Kaighn’s) (Cat. No. 21127, Life Technologies), 45% FBS (Cat. No. 10099-141, Gibco), 10% DMSO (Cat. No. D2650, Sigma)

  • CHO-K1/GLP1R/Gα15 Stable Cell Line
  • CHO-K1/GLP1R/Gα15 Stable Cell Line

    Figure 1. GLP-1 (7-37)-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/GLP1R/Gα15 cells. The cells were loaded with Calcium-4 prior to being stimulated with agonist GLP-1 (7-37). The intracellular calcium change was measured by FLIPRTETRA. The relative fluorescent units (RFU) were normalized and plotted against the log of the cumulative doses (5-fold dilution) of GLP-1 (7-37) (Mean ± SEM, n = 3). The EC50 of GLP-1 (7-37) on this cell was 0.14 μM.

    Notes:
    EC50 value is calculated with four parameter logistic equation:
    Y=Bottom + (Top-Bottom)/(1+10^((LogEC50-X)*Hill Slope))
    X is the logarithm of concentration. Y is the response
    Y is % stimulation of RFU and starts at Bottom and goes to Top with a sigmoid shape.

  • CHO-K1/GLP1R/Gα15 Stable Cell Line
  • CHO-K1/GLP1R/Gα15 Stable Cell Line

    Figure 2. FACS analysis of cell surface expression of GLP1R on CHO-K1/GLP1R/Gα15 stable cell line. The fluorescence signal of the target protein on cell product (red) was compared to negative control (green) and detected with GLP1R Antibody (Cat. No. A01826, GenScript) followed by FITC conjugated Goat anti-Mouse IgG Antibody (H+L) (Cat. No. ab6785, Abcam).

  • CHO-K1/GLP1R/Gα15 Stable Cell Line
  • CHO-K1/GLP1R/Gα15 Stable Cell Line

    Figure 3. Dose dependent stimulation of intracellular cAMP mobilization upon treatment with calcitonin in CHO-K1/GLP1R/Gα15 cells. d2 acceptor fluorophore-labeled cAMP (Cat. No. 62AM4PEC; Revvity) and intracellular cAMP in CHO-K1/GLP1R/Gα15 cells competitively bind with Europium Cryptate-labeled anti-cAMP monoclonal antibody. The FRET signal decreases as the intracellular cAMP concentration rises and was measured by plate reader (Varioskan, Thermo Fisher). The EC50 of GLP-1 (7-37) was 1.84 nM.


For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.


喜歡新升級的網站嗎?

討厭

不喜歡

一般

喜歡

非常喜歡

*
    主站蜘蛛池模板: 塔河县| 讷河市| 永新县| 平乐县| 莱芜市| 墨脱县| 克东县| 商丘市| 左贡县| 家居| 门源| 威信县| 武川县| 铅山县| 上饶市| 渝中区| 犍为县| 洛南县| 洛浦县| 莒南县| 保山市| 商都县| 南宁市| 陆丰市| 芒康县| 吴堡县| 建宁县| 寿光市| 溧水县| 宁河县| 伊春市| 宝兴县| 依兰县| 通渭县| 晋城| 新源县| 长宁区| 永善县| 嵊州市| 兴海县| 镇雄县|